Takehiko Kamijo Selected Research

Phosphoric Monoester Hydrolases (Phosphatases)

7/2011

Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takehiko Kamijo Research Topics

Disease

30	Neoplasms (Cancer) 05/2024 - 07/2003
18	Neuroblastoma 10/2023 - 03/2007
4	Carcinoma (Carcinomatosis) 05/2024 - 02/2022
4	Neoplasm Metastasis (Metastasis) 03/2023 - 10/2018
3	Osteosarcoma (Osteogenic Sarcoma) 05/2023 - 02/2008
3	Lung Neoplasms (Lung Cancer) 01/2014 - 11/2008
2	Disease Progression 01/2023 - 01/2021
2	Chromosome Aberrations (Chromosome Abnormalities) 12/2021 - 10/2004
2	Pancreatic Neoplasms (Pancreatic Cancer) 03/2015 - 11/2012
1	Urinary Bladder Neoplasms (Bladder Cancer) 05/2024
1	COVID-19 11/2023
1	Communicable Diseases (Infectious Diseases) 11/2023
1	Disease Susceptibility (Diathesis) 11/2023
1	Pyruvate Kinase Deficiency of Red Cells 05/2023
1	Inflammation (Inflammations) 03/2023
1	Hepatomegaly 04/2022
1	Papilloma (Papillomatosis) 01/2019
1	Skin Neoplasms (Skin Cancer) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 08/2017
1	Carcinogenesis 07/2017
1	Ataxia Telangiectasia (Louis Bar Syndrome) 05/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Hepatoblastoma 11/2013
1	Oligodendroglioma 07/2011
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 05/2011
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2011
1	Juvenile Myelomonocytic Leukemia 03/2011
1	Residual Neoplasm 03/2011

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 05/2023 - 07/2003
8	DNA (Deoxyribonucleic Acid)IBA 11/2023 - 03/2007
5	Messenger RNA (mRNA)IBA 02/2022 - 07/2010
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
3	pembrolizumabIBA 05/2024 - 02/2022
3	Cisplatin (Platino)FDA LinkGeneric 04/2024 - 03/2007
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2024 - 09/2009
2	Etoposide (VP 16)FDA LinkGeneric 04/2024 - 12/2009
2	AgarIBA 05/2023 - 07/2017
2	A-Form DNA (A-DNA)IBA 04/2023 - 05/2014
2	Small Interfering RNA (siRNA)IBA 04/2023 - 05/2011
2	Hemoglobins (Hemoglobin)IBA 03/2023 - 02/2022
2	Polycomb-Group ProteinsIBA 01/2023 - 05/2011
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 12/2021 - 01/2021
2	AnionsIBA 08/2017 - 01/2014
2	Peptides (Polypeptides)IBA 08/2017 - 01/2014
2	Epidermal Growth Factor (EGF)IBA 07/2017 - 09/2012
2	CarbonIBA 03/2015 - 11/2012
2	Indicators and Reagents (Reagents)IBA 05/2014 - 11/2013
1	PlatinumIBA 05/2024
1	Interferon-gamma (Interferon, gamma)IBA 05/2024
1	Vincristine (Oncovin)FDA LinkGeneric 04/2024
1	Carboplatin (JM8)FDA LinkGeneric 04/2024
1	Melphalan (Alkeran)FDA LinkGeneric 04/2024
1	pirarubicinIBA 04/2024
1	RNA (Ribonucleic Acid)IBA 11/2023
1	Immune Checkpoint InhibitorsIBA 10/2023
1	Platelet-Derived Growth FactorIBA 10/2023
1	DNA Ligases (Ligases, DNA)IBA 05/2023
1	Oncogene Proteins (Oncogene Protein)IBA 05/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2023
1	olaparibIBA 04/2023
1	UNC1999IBA 12/2022
1	Fluorouracil (Carac)FDA LinkGeneric 12/2022
1	Folic Acid (Vitamin M)FDA LinkGeneric 12/2022
1	Thymidylate SynthaseIBA 12/2022
1	Tumor Biomarkers (Tumor Markers)IBA 04/2022
1	Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA 02/2022
1	AlbuminsIBA 02/2022
1	Ferritins (Ferritin)IBA 12/2021
1	Biological FactorsIBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	PF 00477736IBA 01/2020
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	Conditioned Culture MediaIBA 12/2017
1	NeurocanIBA 12/2017
1	Recombinant ProteinsIBA 12/2017
1	Chondroitin Sulfate ProteoglycansIBA 12/2017
1	activin AIBA 07/2017
1	hydrogen sulfite (bisulfite)IBA 06/2016
1	Gemcitabine FDA Link 03/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2013
1	Anaplastic Lymphoma KinaseIBA 05/2013
1	Complementary DNA (cDNA)IBA 05/2013
1	Leucine (L-Leucine)FDA Link 09/2012
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 07/2011
1	TensinsIBA 07/2011
1	ChromatinIBA 05/2011
1	Immunosuppressive Agents (Immunosuppressants)IBA 03/2011
1	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 12/2010
1	Polycomb Repressive Complex 1IBA 07/2010
1	fludarabineIBA 09/2009

Therapy/Procedure

12	Therapeutics 05/2024 - 08/2003
3	Drug Therapy (Chemotherapy) 04/2024 - 04/2012
2	Induction Chemotherapy 04/2024 - 10/2018
2	Transplantation 02/2007 - 10/2004
1	Precision Medicine 01/2023
1	Aftercare (After-Treatment) 01/2023
1	Genomic Medicine 01/2023
1	Radiotherapy 10/2018